タンパク質発現市場：タイプ（大腸菌、哺乳類、CHO、HEK 293、昆虫、Pichia、無細胞）、製品（試薬、ベクター、コンピテントセル、機器、サービス）、用途（治療、産業）、エンドユーザー、地域別 - 2027年までの世界市場予測

Protein Expression Market by Type (E.Coli, Mammalian, CHO, HEK 293, Insect, Pichia, Cell-free), Products (Reagents, Vectors, Competent Cells, Instruments, Service), Application (Therapeutic, Industrial), End User, and Region - Global Forecast to 2027

タンパク質発現の世界市場は、2022年には推定29億米ドルとなり、2027年には予測期間中にCAGR13.3%で54億米ドルに達すると予測されています。その要因としては、ライフサイエンスおよびバイオ医薬品産業の成長、組... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年10月7日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	314	394	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

タンパク質発現の世界市場は、2022年には推定29億米ドルとなり、2027年には予測期間中にCAGR13.3%で54億米ドルに達すると予測されています。その要因としては、ライフサイエンスおよびバイオ医薬品産業の成長、組み換えベースのタンパク質発現に関する研究活動の増加、タンパク質ベースの研究に対する資金調達の可能性などが挙げられます。しかし、タンパク質発現試薬や機器のコストが高いことが、この市場の成長を抑制すると予想されます。
"タンパク質発現市場のシステムタイプ別では、予測期間中、Prokaryotic Expressionシステムセグメントが最も高い成長率を占めた"
2021年、Prokaryotic Expression systemセグメントが最も高い成長率を占めた。最小限のコストで高いレベルのタンパク質生産が可能であることや、生物製剤生産における用途が拡大していることなどが、同市場の成長に有利に働くと考えられます。

"アジア太平洋地域タンパク質発現市場で最も成長率の高い地域"
アジア太平洋地域は、予測期間中に最も高いCAGRを記録すると推定されます。この市場の高い成長率は、バイオテクノロジー産業の急成長、慢性疾患の有病率の上昇、政府によるタンパク質ベースの研究への投資の増加、個別化治療薬に関する意識の高まりに起因しています。また、世界的な企業は、この地域が提供する低コスト製造の優位性から、この地域に着目しています。

本レポートのために実施した主なインタビューは、以下のように分類されます。

- 回答者別回答者別：供給側60％、需要側40
- 職位別Cレベル（マネージャー）-45%、Dレベル（CXO、ディレクター）-30%、その他（エグゼクティブ）-25
- 地域別北米：20％、欧州：10％、アジア太平洋：55％、中南米：10％、中東・アフリカ：5
報告書に掲載された企業一覧
- サーモフィッシャーサイエンティフィック社（米国）
- Merck KGaA (ドイツ)
- GenScript Biotech Corporation（米国）
- アジレント・テクノロジー株式会社（米国）
- タカラバイオ株式会社（日本）
- バイオ・ラッド・ラボラトリーズ, Inc.（米国）
- Qiagen N.V（オランダ）
- チャールズ・リバー・ラボラトリーズ, Inc.
- ダナハーコーポレーション（米国）
- ザルトリウスAG（ドイツ）
- コーニング・インコーポレイテッド（米国）
- 富士フイルムアーバインサイエンティフィック株式会社（日本）
- ロンザグループAG（スイス）
- ビオネア株式会社 (韓国)
- プロメガ・コーポレーション（米国）
- オックスフォード・エクスプレッション・テクノロジーズ社（英国(イギリス)
- プロテオジェニックス社（フランス）
- アベオミックス社（米国）
- ニューイングランド・バイオラブズ社（米国）
- プロマブ・バイオテクノロジーズ（米）
- シノバイオロジカル社（中国）
- イエナバイオサイエンス（ドイツ）
- ライフセンサーズ社（米国）
- リーディングバイオロジー社（米国）
- Peak Proteins（イギリス）
調査対象範囲
本レポートは、世界のタンパク質発現市場の詳細な情報を提供します。システムタイプ、製品・サービス、アプリケーション、エンドユーザー、地域などの異なるセグメントにおける市場規模および今後の成長性を推定することを目的としています。また、主要な市場プレイヤーの詳細な競合分析、企業プロファイル、最近の開発状況、主要な市場戦略も掲載しています。

レポート購入の主なメリット
本レポートは、タンパク質発現市場全体とそのサブセグメントに関する収益数の最も近い概算を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競争環境をより良く理解し、より良いビジネスの位置付けと適切な市場参入戦略を立てるためのより多くの洞察を得るのに役立ちます。本レポートは、利害関係者が市場の脈動を理解し、主要な市場促進要因、課題、阻害要因、傾向、機会に関する情報を提供することを可能にします。

ページTOPに戻る

1 INTRODUCTION 43
1.1 STUDY OBJECTIVES 43
1.2 MARKET DEFINITION 43
1.2.1 INCLUSIONS AND EXCLUSIONS 43
1.3 MARKET SCOPE 44
1.3.1 MARKETS COVERED 44
1.3.2 YEARS CONSIDERED 45
1.4 CURRENCY CONSIDERED 45
1.5 LIMITATIONS 45
1.6 STAKEHOLDERS 45
1.7 SUMMARY OF CHANGES 46
2 RESEARCH METHODOLOGY 47
2.1 RESEARCH DATA 47
FIGURE 1 RESEARCH DESIGN 47
2.1.1 SECONDARY DATA 47
2.1.2 PRIMARY DATA 48
FIGURE 2 BREAKDOWN OF PRIMARIES 49
2.2 MARKET ESTIMATION METHODOLOGY 50
FIGURE 3 PROTEIN EXPRESSION MARKET SIZE ESTIMATION (SUPPLY SIDE ANALYSIS), 2021 50
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021 51
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 52
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 52
2.3 MARKET GROWTH RATE PROJECTIONS 53
FIGURE 6 PROTEIN EXPRESSION MARKET (SUPPLY SIDE): CAGR PROJECTIONS 53
FIGURE 7 PROTEIN EXPRESSION MARKET (DEMAND SIDE): GROWTH ANALYSIS OF FACTORS 54
2.3.1 DATA TRIANGULATION 55
FIGURE 8 DATA TRIANGULATION METHODOLOGY 55
2.4 RESEARCH ASSUMPTIONS 56
2.4.1 COVID-19-SPECIFIC ASSUMPTIONS 56
2.5 RISK ANALYSIS 57
3 EXECUTIVE SUMMARY 58
FIGURE 9 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022 VS. 2027 (USD MILLION) 58
FIGURE 10 PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 59
FIGURE 11 PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION) 59
FIGURE 12 PROTEIN EXPRESSION MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 60
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF PROTEIN EXPRESSION MARKET 61
4 PREMIUM INSIGHTS 62
4.1 PROTEIN EXPRESSION MARKET OVERVIEW 62
FIGURE 14 INCREASING DEMAND FOR PROTEIN BIOLOGICS TO DRIVE MARKET 62
4.2 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE AND COUNTRY (2021) 63
FIGURE 15 US TO COMMAND LARGEST SHARE OF NORTH AMERICAN PROTEIN EXPRESSION MARKET IN 2021 63
4.3 PROTEIN EXPRESSION MARKET SHARE, BY SYSTEM TYPE, 2022 VS. 2027 64
FIGURE 16 MAMMALIAN CELL EXPRESSION SYSTEM TO DOMINATE MARKET IN 2027 64
4.4 PROTEIN EXPRESSION MARKET SHARE, BY END USER, 2022 64
FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BE LARGEST END USERS 64
4.5 PROTEIN EXPRESSION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 65
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 65
5 MARKET OVERVIEW 66
5.1 INTRODUCTION 66
5.2 MARKET DYNAMICS 66
FIGURE 19 PROTEIN EXPRESSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 66
5.2.1 DRIVERS 67
5.2.1.1 Increasing demand for protein biologics 67
TABLE 1 BIOLOGICS AND CELL LINES USED 67
TABLE 2 BIOLOGICS APPROVED BY FDA IN 2021 68
TABLE 3 PROTEINS SYNTHESIZED BY PROTEIN EXPRESSION AND GENETIC ENGINEERING 69
FIGURE 20 DIABETES CASES, BY REGION, 2021 VS. 2045 (MILLION) 69
TABLE 4 GLOBAL INCIDENCE OF CANCER, BY TYPE (2020) 70
5.2.1.2 Increasing R&D in pharmaceutical and biopharmaceutical industries 70
5.2.1.3 Growing adoption of recombinant-based protein expression 71
5.2.1.4 Availability of funding for protein-based research 71
TABLE 5 GOVERNMENT FUNDING FOR PROTEIN-BASED RESEARCH (2017–2022) 72
5.2.2 RESTRAINTS 73
5.2.2.1 High cost of protein expression reagents and instruments 73
TABLE 6 AVERAGE SELLING PRICE OF DIFFERENT TYPES OF MEDIA/1000 L IN DEVELOPED AND DEVELOPING COUNTRIES (2020) 73
5.2.2.2 Increasing consolidation and high barriers for new entrants 74
5.2.3 OPPORTUNITIES 74
5.2.3.1 Emergence of microfluidics 74
5.2.3.2 Emerging economies offering significant growth potential 74
5.2.4 CHALLENGE 75
5.2.4.1 Undesired post-translational modifications and purification 75
5.3 RANGES/SCENARIOS 76
FIGURE 21 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF PROTEIN EXPRESSION MARKET 76
FIGURE 22 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 76
5.4 PRICING ANALYSIS 77
5.5 TECHNOLOGY ANALYSIS 77
TABLE 7 ADVANTAGES AND CHALLENGES OF RECOMBINANT PROTEIN EXPRESSION SYSTEMS 77
5.6 PATENT ANALYSIS 79
FIGURE 23 PATENT APPLICATIONS FOR PROTEIN EXPRESSION MARKET, JANUARY 2011–MAY 2022 79
TABLE 8 INDICATIVE PATENT IN PROTEIN EXPRESSION MARKET 79
5.7 VALUE CHAIN ANALYSIS 80
FIGURE 24 VALUE CHAIN ANALYSIS: RAW MATERIAL AND MANUFACTURING PHASE TO CONTRIBUTE MAXIMUM VALUE 80
5.8 SUPPLY CHAIN ANALYSIS 81
FIGURE 25 PROTEIN EXPRESSION MARKET: SUPPLY CHAIN ANALYSIS 82
5.9 ECOSYSTEM ANALYSIS 82
TABLE 9 SUPPLY CHAIN ECOSYSTEM 83
5.10 KEY CONFERENCES AND EVENTS IN 2022–2023 84
TABLE 10 PROTEIN EXPRESSION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 84
5.11 REGULATORY ANALYSIS 85
5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 11 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 13 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86
TABLE 14 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86
5.12 PORTER’S FIVE FORCES ANALYSIS 87
TABLE 15 PROTEIN EXPRESSION MARKET: PORTER’S FIVE FORCES ANALYSIS 87
5.12.1 THREAT OF NEW ENTRANTS 87
5.12.2 THREAT OF SUBSTITUTES 87
5.12.3 BARGAINING POWER OF SUPPLIERS 87
5.12.4 BARGAINING POWER OF BUYERS 87

5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 88
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 88
FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF PROTEIN EXPRESSION PRODUCTS AND SERVICES 88
5.13.2 BUYING CRITERIA FOR PROTEIN EXPRESSION PRODUCTS 88
FIGURE 27 KEY BUYING CRITERIA FOR END USERS 88
6 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE 89
6.1 INTRODUCTION 90
TABLE 16 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 90
6.2 MAMMALIAN CELL EXPRESSION SYSTEMS 90
TABLE 17 PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 91
TABLE 18 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 91
TABLE 19 EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 92
TABLE 20 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 92
TABLE 21 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 93
TABLE 22 MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 93
6.2.1 CHINESE HAMSTER OVARY CELL SYSTEMS (CHO CELL SYSTEMS) 93
6.2.1.1 Chinese hamster ovary cell systems to dominate market 93
TABLE 23 PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 94
TABLE 24 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 94
TABLE 25 EUROPE: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 94
TABLE 26 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 95
TABLE 27 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 95
6.2.2 HUMAN EMBRYONIC KIDNEY CELL SYSTEMS (HEK 293 CELL SYSTEMS) 95
6.2.2.1 Increasing use of HEK 293 cells for producing biologics to boost market 95
TABLE 28 PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 96
TABLE 29 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 96
TABLE 30 EUROPE: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 97
TABLE 31 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 97
TABLE 32 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 98
6.2.3 OTHER MAMMALIAN CELL SYSTEMS 98
TABLE 33 PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 98
TABLE 34 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 99
TABLE 35 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 99
TABLE 36 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 100
TABLE 37 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 100
6.3 PROKARYOTIC EXPRESSION SYSTEMS 100
TABLE 38 PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 101
TABLE 39 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 101
TABLE 40 EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 102
TABLE 41 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 102
TABLE 42 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 103
TABLE 43 PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 103
6.3.1 ESCHERICHIA COLI SYSTEMS 103
6.3.1.1 Increasing use of E. coli systems for commercial protein production to fuel market 103
TABLE 44 PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 104
TABLE 45 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 104
TABLE 46 EUROPE: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 104
TABLE 47 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 105
TABLE 48 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 105
6.3.2 OTHER PROKARYOTIC EXPRESSION SYSTEMS 105
TABLE 49 PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 106
TABLE 50 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 106
TABLE 51 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 107
TABLE 52 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 107
TABLE 53 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 108
6.4 INSECT CELL EXPRESSION SYSTEMS 108
TABLE 54 PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 108
TABLE 55 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 109
TABLE 56 EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 109
TABLE 57 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 110
TABLE 58 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 110
TABLE 59 INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 110
6.4.1 BACULOVIRUS SYSTEMS 111
6.4.1.1 Baculovirus systems to show high yield and expression levels for intracellular proteins 111
TABLE 60 PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 111
TABLE 61 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 111
TABLE 62 EUROPE: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 63 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 64 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 113
6.4.2 OTHER INSECT CELL SYSTEMS 113
TABLE 65 PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 113
TABLE 66 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 114
TABLE 67 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 114
TABLE 68 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 115
TABLE 69 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 115
6.5 YEAST EXPRESSION SYSTEMS 115
TABLE 70 PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 116
TABLE 71 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 116
TABLE 72 EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 117
TABLE 73 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 117
TABLE 74 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 118
TABLE 75 YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
6.5.1 PICHIA SYSTEMS 118
6.5.1.1 Pichia systems to hold largest market share 118
TABLE 76 PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 119
TABLE 77 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 119
TABLE 78 EUROPE: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 119
TABLE 79 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 120
TABLE 80 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 120
6.5.2 SACCHAROMYCES SYSTEMS 120
6.5.2.1 Saccharomyces systems to channelize direction of foreign proteins into secretory pathways using various signals 120
TABLE 81 PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 121
TABLE 82 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 83 EUROPE: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 84 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 122
TABLE 85 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 122
6.5.3 OTHER YEAST EXPRESSION SYSTEMS 122
TABLE 86 PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 123
TABLE 87 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 88 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 89 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 124
TABLE 90 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 124
6.6 CELL-FREE EXPRESSION SYSTEMS 124
6.6.1 INCREASING DEMAND FOR RECOMBINANT PROTEINS TO SUPPORT MARKET 124
TABLE 91 PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 125
TABLE 92 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 125
TABLE 93 EUROPE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 125
TABLE 94 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 126
TABLE 95 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 126
6.7 ALGAL-BASED EXPRESSION SYSTEMS 126
6.7.1 GROWTH IN VACCINES MARKET TO SUPPORT SEGMENT 126
TABLE 96 PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 127
TABLE 97 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 127
TABLE 98 EUROPE: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 127
TABLE 99 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 128
TABLE 100 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 128
7 PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE 129
7.1 INTRODUCTION 130
TABLE 101 PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 130
7.2 REAGENTS 130
7.2.1 REAGENTS TO DOMINATE MARKET DURING FORECAST PERIOD 130
TABLE 102 PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2020–2027 (USD MILLION) 131
TABLE 103 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 131
TABLE 104 EUROPE: PROTEIN EXPRESSION MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 131
TABLE 105 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 132
TABLE 106 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR REAGENTS, BY REGION, 2020–2027 (USD MILLION) 132
7.3 EXPRESSION VECTORS 132
7.3.1 EXPRESSION VECTORS TO BE INDISPENSABLE FOR PROTEIN EXPRESSION 132
TABLE 107 PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY REGION, 2020–2027 (USD MILLION) 133
TABLE 108 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2020–2027 (USD MILLION) 133
TABLE 109 EUROPE: PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2020–2027 (USD MILLION) 134
TABLE 110 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2020–2027 (USD MILLION) 134
TABLE 111 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY REGION, 2020–2027 (USD MILLION) 134

7.4 COMPETENT CELLS 135
7.4.1 INCREASING DEMAND FOR THERAPEUTIC PROTEINS TO DRIVE MARKET 135
TABLE 112 PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY REGION, 2020–2027 (USD MILLION) 135
TABLE 113 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY COUNTRY, 2020–2027 (USD MILLION) 136
TABLE 114 EUROPE: PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY COUNTRY, 2020–2027 (USD MILLION) 136
TABLE 115 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY COUNTRY, 2020–2027 (USD MILLION) 137
TABLE 116 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY REGION, 2020–2027 (USD MILLION) 137
7.5 INSTRUMENTS 137
7.5.1 INSTRUMENTS TO EFFICIENTLY TRANSFER GENETIC MATERIALS INTO HOST CELLS 137
TABLE 117 PROTEIN EXPRESSION MARKET FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION) 138
TABLE 118 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSTRUMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 138
TABLE 119 EUROPE: PROTEIN EXPRESSION MARKET FOR INSTRUMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 139
TABLE 120 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSTRUMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 139
TABLE 121 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION) 140
7.6 SERVICES 140
7.6.1 RISING DEMAND FOR CUSTOMIZED PROTEINS TO PROPEL MARKET 140
TABLE 122 PROTEIN EXPRESSION MARKET FOR SERVICES, BY REGION, 2020–2027 (USD MILLION) 140
TABLE 123 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR SERVICES, BY COUNTRY, 2020–2027 (USD MILLION) 141
TABLE 124 EUROPE: PROTEIN EXPRESSION MARKET FOR SERVICES, BY COUNTRY, 2020–2027 (USD MILLION) 141
TABLE 125 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR SERVICES, BY COUNTRY, 2020–2027 (USD MILLION) 142
TABLE 126 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR SERVICES, BY REGION, 2020–2027 (USD MILLION) 142
8 PROTEIN EXPRESSION MARKET, BY APPLICATION 143
8.1 INTRODUCTION 144
TABLE 127 PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 144
8.2 THERAPEUTIC APPLICATIONS 144
8.2.1 THERAPEUTIC PROTEINS TO TREAT PATHOLOGICAL CONDITIONS 144
TABLE 128 THERAPEUTIC PROTEINS AND INDICATION 145
TABLE 129 PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 146
TABLE 130 NORTH AMERICA: THERAPEUTIC APPLICATIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 146
TABLE 131 EUROPE: THERAPEUTIC APPLICATIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 146
TABLE 132 ASIA PACIFIC: THERAPEUTIC APPLICATIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 147
TABLE 133 REST OF THE WORLD: THERAPEUTIC APPLICATIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 147
8.3 RESEARCH APPLICATIONS 147
8.3.1 INCREASING INVESTMENTS IN RESEARCH ACTIVITIES TO DRIVE SEGMENT 147
TABLE 134 PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 148
TABLE 135 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 148
TABLE 136 EUROPE: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 149
TABLE 137 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 149
TABLE 138 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 150
8.4 INDUSTRIAL APPLICATIONS 150
8.4.1 GROWTH IN EXPRESSION SYSTEMS FOR INDUSTRIAL ENZYMES PRODUCTION TO SUPPORT SEGMENT 150
TABLE 139 PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 151
TABLE 140 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 151
TABLE 141 EUROPE: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 151
TABLE 142 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 152
TABLE 143 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 152
9 PROTEIN EXPRESSION MARKET, BY END USER 153
9.1 INTRODUCTION 154
TABLE 144 PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 154
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 154
9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE END USERS MARKET 154
TABLE 145 PROTEIN EXPRESSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION) 155
TABLE 146 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 155
TABLE 147 EUROPE: PROTEIN EXPRESSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 155
TABLE 148 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 156
TABLE 149 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION) 156
9.3 ACADEMIC RESEARCH INSTITUTES 156
9.3.1 INCREASING GOVERNMENT AND PRIVATE FUNDING TO SUPPORT MARKET 156
TABLE 150 PROTEIN EXPRESSION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION) 157
TABLE 151 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 157
TABLE 152 EUROPE: PROTEIN EXPRESSION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 158
TABLE 153 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 158
TABLE 154 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION) 159
9.4 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CROS & CDMOS) 159
9.4.1 CLINICAL TRIALS, OUTSOURCING, AND COLLABORATIONS FOR PHARMACEUTICAL MANUFACTURING TO BOOST MARKET 159
TABLE 155 PROTEIN EXPRESSION MARKET FOR CROS & CDMOS, BY REGION, 2020–2027 (USD MILLION) 160
TABLE 156 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CROS & CDMOS, BY COUNTRY, 2020–2027 (USD MILLION) 160
TABLE 157 EUROPE: PROTEIN EXPRESSION MARKET FOR CROS & CDMOS, BY COUNTRY, 2020–2027 (USD MILLION) 160
TABLE 158 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CROS & CDMOS, BY COUNTRY, 2020–2027 (USD MILLION) 161
TABLE 159 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR CROS & CDMOS, BY REGION, 2020–2027 (USD MILLION) 161
9.5 OTHER END USERS 161
TABLE 160 PROTEIN EXPRESSION MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION) 162
TABLE 161 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 162
TABLE 162 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 162
TABLE 163 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 163
TABLE 164 ROW: PROTEIN EXPRESSION MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION) 163
10 PROTEIN EXPRESSION MARKET, BY REGION 164
10.1 INTRODUCTION 165
TABLE 165 PROTEIN EXPRESSION MARKET, BY REGION, 2020–2027 (USD MILLION) 165
10.2 NORTH AMERICA 165
FIGURE 28 NORTH AMERICA: PROTEIN EXPRESSION MARKET SNAPSHOT 166
TABLE 166 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 166
TABLE 167 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 167
TABLE 168 NORTH AMERICA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 167
TABLE 169 NORTH AMERICA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 170 NORTH AMERICA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 171 NORTH AMERICA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 172 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 169
TABLE 173 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 169
TABLE 174 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 170
10.2.1 US 170
10.2.1.1 US to dominate global protein expression market 170
TABLE 175 US: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 171
TABLE 176 US: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 177 US: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 178 US: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 179 US: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 180 US: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 173
TABLE 181 US: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 173
TABLE 182 US: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 174
10.2.2 CANADA 174
10.2.2.1 Government funding for research and innovation to support market 174
TABLE 183 CANADA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 175
TABLE 184 CANADA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 185 CANADA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 186 CANADA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 187 CANADA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 188 CANADA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 177
TABLE 189 CANADA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 177
TABLE 190 CANADA: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 178
10.3 EUROPE 178
TABLE 191 EUROPE: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 179
TABLE 192 EUROPE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 179
TABLE 193 EUROPE: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 194 EUROPE: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 195 EUROPE: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 196 EUROPE: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 197 EUROPE: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 181
TABLE 198 EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 181
TABLE 199 EUROPE: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 182
10.3.1 GERMANY 182
10.3.1.1 Germany to dominate market share in Europe 182
TABLE 200 GERMANY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 183
TABLE 201 GERMANY: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 202 GERMANY: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 184
TABLE 203 GERMANY: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 184
TABLE 204 GERMANY: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 184
TABLE 205 GERMANY: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 185
TABLE 206 GERMANY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 185
TABLE 207 GERMANY: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 186
10.3.2 UK 186
10.3.2.1 Surge in number of chronic diseases to boost market 186
TABLE 208 UK: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 187
TABLE 209 UK: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 187
TABLE 210 UK: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 211 UK: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 212 UK: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 213 UK: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 189
TABLE 214 UK: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 189
TABLE 215 UK: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 190
10.3.3 FRANCE 190
10.3.3.1 Increasing biotech R&D to drive market 190
TABLE 216 FRANCE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 191
TABLE 217 FRANCE: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 218 FRANCE: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 219 FRANCE: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 220 FRANCE: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 221 FRANCE: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 193
TABLE 222 FRANCE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 193
TABLE 223 FRANCE: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 194
10.3.4 ITALY 194
10.3.4.1 Increase in life sciences research projects to fuel market 194
TABLE 224 ITALY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 195
TABLE 225 ITALY: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 226 ITALY: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 227 ITALY: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 228 ITALY: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 229 ITALY: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 197
TABLE 230 ITALY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 197
TABLE 231 ITALY: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 198

ページTOPに戻る

Table of Contents

Summary

The global Protein Expression market is valued at an estimated USD 2.9 billion in 2022 and is projected to reach USD 5.4 billion by 2027, at a CAGR of 13.3% during the forecast period. Factors such as the growth in the life science and biopharmaceutical industries, increasing research activities on recombinant-based protein expression, and the availability of funding for protein-based research. However, the high cost of protein expression reagents and instruments is expected to restrain the growth of this market.
“The Prokaryotic Expression system segment accounted for the highest growth rate in the Protein Expression market, by System Type, during the forecast period”
In 2021, the Prokaryotic Expression system segment accounted for the highest growth rate. Factors such as high level of protein production at a minimal cost, and their increasing applications in biologics production will favor the growth of this market.

“Asia Pacific: The fastest-growing region in the Protein Expression market”
The Asia Pacific market is estimated to record the highest CAGR during the forecast period. The high growth rate of this market can be attributed to the rapid growth of the biotechnology industry, the rising prevalence of chronic disorders, increasing investments by governments in protein-based research, and rising awareness about personalized therapeutics. Besides, global players are focused on this region for the low-cost manufacturing advantage that it provides.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 60% and Demand Side 40%
• By Designation: C-level (Managers) - 45%, D-level (CXOs, Directors)- 30%, and Others (Executives) - 25%
• By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, Middle East & Africa- 5%
List of Companies Profiled in the Report:
• Thermo Fisher Scientific, Inc (US)
• Merck KGaA (Germany)
• GenScript Biotech Corporation (US)
• Agilent Technologies, Inc. (US)
• Takara Bio, Inc. (Japan)
• Bio-Rad Laboratories, Inc. (US)
• Qiagen N.V (Netherlands)
• Charles River Laboratories, Inc. (US)
• Danaher Corporation (US)
• Sartorius AG (Germany)
• Corning Incorporated (US)
• FUJIFILM Irvine Scientific, Inc. (Japan)
• Lonza Group AG (Switzerland)
• Bioneer Corporation (South Korea)
• Promega Corporation (US)
• Oxford Expression Technologies Ltd. (UK)
• ProteoGenix (France)
• Abeomics, Inc. (US)
• New England Biolabs, Inc. (US)
• Promab Biotechnologies (US)
• Sino Biological, Inc. (China)
• Jena Bioscience (Germany)
• Lifesensors, Inc. (US)
• Leading biology, Inc. (US)
• Peak Proteins (UK)
Research Coverage:
This report provides a detailed picture of the global Protein Expression Market. It aims at estimating the size and future growth potential of the market across different segments such as the system type, product & service, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall Protein Expression Market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, challenges, restraints, trends, and opportunities.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

MarketsandMarkets社のその他分野での最新刊レポート

本レポートと同じKEY WORD（protein）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

MarketsandMarkets社のその他分野での最新刊レポート

本レポートと同じKEY WORD（protein）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?